Sara Alson

No ORCID on file · 13 papers in corpus · active 2022-2026

Study types

  • article 9
  • other 4

Condition tags

  • adenomyosis 10
  • endometriosis 7
  • endometrioma 3
  • mesh:D004715 3
  • die_deep_infiltrating 2
  • dysmenorrhea 1
  • dyspareunia 1
other 2026
Scientific reports ·doi:10.1038/s41598-025-31013-1

UNLABELLED: Predicting live birth after the first IVF/ICSI treatment is challenging, as many factors may interact to affect IVF/ICSI outcomes. Adenomyosis is one factor that impacts live birth rates. Machine learning algorithms have been sh…

article 2025
Human Reproduction ·doi:10.1093/humrep/deaf184

STUDY QUESTION: Does endometriosis and/or adenomyosis, diagnosed using the International Deep Endometriosis Analysis (IDEA) group and the Morphological Uterus Sonographic Assessment (MUSA) group revised definitions, impact cumulative live b…

other 2025
·doi:10.5281/zenodo.17715462

XGBoost-based machine learning models for predicting live birth rates following in vitro fertilization (IVF) treatment, incorporating ultrasound features of adenomyosis based on the Morphological Uterus Sonographic Assessment (MUSA) criteri…

other 2025
·doi:10.5281/zenodo.17715463

XGBoost-based machine learning models for predicting live birth rates following in vitro fertilization (IVF) treatment, incorporating ultrasound features of adenomyosis based on the Morphological Uterus Sonographic Assessment (MUSA) criteri…

article 2024
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.14986

INTRODUCTION: Data regarding the impact of adenomyosis on the outcomes after in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment are conflicting. Standardized diagnostic criteria are prerequisites for studying …

article 2024
Fertility and sterility ·doi:10.1016/j.fertnstert.2024.01.023

OBJECTIVE: To study the cumulative live birth rate (CLBR) after the first in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment in women with or without deep-infiltrating endometriosis (DIE) and/or endometrioma d…

article 2024
·doi:10.1002/uog.27797

To determine the cumulative live birth rate (CLBR) after the first in vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) treatment in women with or without direct features of adenomyosis, using the revised Morphological Ut…

article 2024
·doi:10.1002/uog.27799

To determine the cumulative live birth rate (CLBR) after the first in vitro fertilization (IVF) treatment in women without direct features, but with or without indirect features of adenomyosis, described using the revised Morphological Uter…

article 2024
·doi:10.1002/uog.27964

To determine the predictive value of Morphological Uterus Sonographic Assessment (MUSA) group features of adenomyosis on cumulative live birth (CLB) after the first in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) tre…

article 2024
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.14812

INTRODUCTION: Studies that use standardized ultrasonographic criteria to diagnose adenomyosis in subfertile women are needed. These would improve the understanding of the disease burden and enable further studies on its impact on fertility …

article 2023
·doi:10.1002/uog.27119

To determine the prevalence of direct and indirect features of adenomyosis, as defined by the revised Morphological Uterus Sonographic Assessment (MUSA) group, in infertile women. Infertile women aged 25–39 years, scheduled for their first …

article 2022
·doi:10.1002/uog.25161
other 2022
Fertility and sterility ·doi:10.1016/j.fertnstert.2022.07.024

OBJECTIVE: To estimate the prevalence of endometrioma and deep infiltrating endometriosis (DIE), assessed by systematic transvaginal ultrasound examination, in women with subfertility accepted for their first assisted reproductive treatment…